Thu Nov 17 15:22:34 EST 1994

Hi there!

I am wondering if anyone can answer a question I have regarding the use of
clinically isolated human secretory IgA in an eliza.  I want to know if the
secretory component of the antibody will inhibit binding of the secondary
antibody (peroxidase labeled goat IgG anti human IgA) and/or the development
of the eliza.  Any other information regarding the use of s-IgA in
lab protocols that may cause it to react differently than "normal"
antibodies would be appreciated!

Thanks in advance for any help!

Lynne Whitehead
U of Maryland - Microbiology Dept.

More information about the Immuno mailing list